共 50 条
[21]
Targeted Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Tafasitamab in Context
[J].
ONCOTARGETS AND THERAPY,
2023, 16
:617-629
[25]
Relapsed or Refractory Diffuse Large B-Cell Lymphoma: "Dazed and Confused"
[J].
ONCOLOGY-NEW YORK,
2022, 36 (06)
:360-369
[29]
High-dose rituximab in combination with autologous stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma
[J].
MEDICINA CLINICA,
2020, 155 (06)
:235-241